1. Organization 12th Dutch Hematology Congress
Up until 2017 the Dutch Hematology Congress was organized annually the HOVON Foundation and the Dutch Society of Hematology (NVvH). In August 2017, all congress related activities of the HOVON Foundation and the NVvH were merged together in the newly founded DHC Foundation.
A project team, especially put together for DHC, is responsible for the overall organisation of the congress. The team plays an important role in optimizing communication and co-operation between all parties that are involved with this event.
|Project leader||Regina Knoester|
|Professional leader||Dr. Marten Niijziel|
|Chairmen||Prof.dr. Jan Cornelissen and Prof.dr. Nicole Blijlevens|
|Treasurer||Dr. Lidwine Tick|
|Chair program committee||Prof.dr. Marie José Kersten|
|Vice chair program committee||Dr. Stijn Halkes|
|Project assistents||Susanne Højsgaard-Tabbers & Saskia Broekman|
|Nursing Symposium||Judith van Deursen|
The Program Committee is responsible for composing the program and inviting the speakers. This Program Committee consists of representatives from HOVON, NVvH, Experimental Hematology, KWF Lymphoma group, stem cell transplantation group, and the fellows. Key persons are appointed to select the speakers for the fundamental and translational research sessions. Click here to find out more about this new set up of these presentations.
Prof. dr. Marie José Kersten (chair)
Dr. Stijn Halkes (vice-chair)
Dr. Marten Nijziel (project leader program)
Members of the Program Committee (in no particular order)
Dr. Bert van der Reijden
Dr. Joost Kluiver
Dr. Marc Raaijmakers
Dr. Hein Schepers
Dr. Lotte Wieten
Dr. Marcel Spaargaren
Dr. Inge Jedema
Dr. Willemijn Hobo
Prof. dr. Jeroen Eikenboom
Dr. Reinier Raymakers
Dr. Bea Tanis
Dr. Harry Koene
Dr. Michel Schaap
Dr. Annemiek Broyl
Prof. dr. Gerwin Huls
Dr. André Mulder
Dr. Linde Morsink
Dr. Geerte van Sluis
|Research Field||Key Persons|
|Benigne, Hemostasis, Thrombosis||Prof. dr. Frank Leebeek, Prof. dr. Jeroen Eikenboom, Prof. dr. Sacha Zeerleder|
|Myeloid||Dr. Marc Raaijmakers, Dr. Arjan van de Loosdrecht|
|Hematopoiesis||Dr. Marieke von Lindern, Prof. dr. Gerald de Haan|
|Lymphoid||Dr. Joost Kluiver, Dr. Marcel Spaargaren|
|Immunology||Dr. Harry Dolstra, Prof. dr. Fred Falkenburg|
During the congress, an executive team is present to assist you. The executive team consists of: Regina Knoester (Project Manager), Susanne Højsgaard-Tabbers and Saskia Broekman.
2. Organization 7th Nursing Symposium to the top
Board en committee
• Board SIG Hematology, V&VN Oncology
Maaike de Ruijter, voorzitter (Spaarne Gasthuis, Hoofddorp)
Carolien Burghout, secretaris (Jeroen Bosch Ziekenhuis, ’s-Hertogenbosch)
Lian Schoonhoven-Bos, algemeen lid (UMC Utrecht)
Nicolette Zwinkels, algemeen lid (Haga Ziekenhuis, Den Haag)
Patty Bosman, algemeen lid (VUmc, Amsterdam)
Reny Kuiper, algemeen lid (AMC/EKZ, Amsterdam)
• Program committee
Linda Luppens-de Graaf (Esperanz/Westfriesgasthuis, Hoorn)
Tineke Duyts (Medisch Spectrum Twente, Enschede)
Judith van Deursen (Maxima Medisch Centrum, Veldhoven)
Shahira Fazel (Radboudumc, Nijmegen)
Mirjam Oudshoorn (LUMC, Leiden)
3. DHC Foundation to the top
Since August 2017, the congress activities of the HOVON Foundation and the NVvH are merged into the newly founded DHC Foundation. The main reason for the establishment of this new foundation, is to provide transparancy in both activities and financial flows. The members of the board of the DHC Foundation are:
|Prof. dr. Nicole Blijlevens||Chair|
|Prof. dr. Jan Cornelissen||Vice-Chair|
|Dr. Lidwine Tick||Treasurer|
|Dr. Gert Ossenkoppele||Secretary|
4. HOVON Foundation to the top
On October 1, 1985, six prominent internists, hematologists from different academic hospitals, founded the HOVON Foundation (Hemato-oncology for Adults the Netherlands) in Rotterdam. HOVON aims to promote 'the optimal treatment of adult patients with haematological malignant diseases'. The best way to obtain this optimal treatment is through the creation and implementation of clinical studies in which as many patients as possible are able to participate.
Because hemato-oncological diseases are rare in terms of frequency, it is necessary to make the required expertise for treatment quickly available to patients. This is realised by creating and managing networks of doctors in various hospitals.
For further information on the HOVON Foundation, visit the website.
5. Dutch Society of Hematology (NVvH) to the top
The Dutch Society of Hematology (NVvH), founded in 1950, is the national organization of blood experts. Around 440 doctors and biomedical scientists working in the field of patient care, research and education of diseases of the blood and blood-forming tissues.
The NVvH has a co-ordinating role and is an umbrella organization for associations operating in the different areas of hematology. This coordinating role improves the position of hematology as to patient care, education and research, and prevents fragmentation of Dutch hematology.
A close co-operation exists with the sub- and sister organizations, including representation in the board of the NVvH, and by organizing joint meetings.
For further information about the Dutch Society of Hematology (NVvH), visit the website.